These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 14531813)

  • 21. Cardiovascular abnormalities in children with autosomal dominant polycystic kidney disease.
    Ivy DD; Shaffer EM; Johnson AM; Kimberling WJ; Dobin A; Gabow PA
    J Am Soc Nephrol; 1995 Jun; 5(12):2032-6. PubMed ID: 7579051
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Magnetic resonance measurements of renal blood flow as a marker of disease severity in autosomal-dominant polycystic kidney disease.
    King BF; Torres VE; Brummer ME; Chapman AB; Bae KT; Glockner JF; Arya K; Felmlee JP; Grantham JJ; Guay-Woodford LM; Bennett WM; Klahr S; Hirschman GH; Kimmel PL; Thompson PA; Miller JP;
    Kidney Int; 2003 Dec; 64(6):2214-21. PubMed ID: 14633145
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparison of the effects of ramipril and losartan on blood pressure control and left ventricle hypertrophy in patients with autosomal dominant polycystic kidney disease.
    Ulusoy S; Ozkan G; Orem C; Kaynar K; Koşucu P; Kiriş A
    Ren Fail; 2010; 32(8):913-7. PubMed ID: 20722556
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ambulatory blood pressure correlates with renal volume and number of renal cysts in children with autosomal dominant polycystic kidney disease.
    Seeman T; Dusek J; Vondrichová H; Kyncl M; John U; Misselwitz J; Janda J
    Blood Press Monit; 2003 Jun; 8(3):107-10. PubMed ID: 12900587
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NOS3 tagSNPs does not modify the chronic kidney disease progression in autosomal dominant polycystic kidney disease.
    Ramanathan G; Periyasamy S; Lakkakula BV
    Nephrology (Carlton); 2014 Sep; 19(9):537-41. PubMed ID: 24824375
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A promoter polymorphism of the alpha 8 integrin gene and the progression of autosomal-dominant polycystic kidney disease.
    Zeltner R; Hilgers KF; Schmieder RE; Porst M; Schulze BD; Hartner A
    Nephron Clin Pract; 2008; 108(3):c169-75. PubMed ID: 18277079
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Two cases of autosomal dominant polycystic kidney diseases who presented bilateral enlarged kidneys and severe hypertension in the neonatal period].
    Wakaki H; Ikeda M; Hataya H; Ishikura K; Nakashima T; Oosako Y; Honda M
    Nihon Jinzo Gakkai Shi; 2004 Oct; 46(7):719-23. PubMed ID: 15570901
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reliability of magnetic resonance imaging for measuring the volumetric indices in autosomal-dominant polycystic kidney disease: correlation with hypertension and renal function.
    Lee YR; Lee KB
    Nephron Clin Pract; 2006; 103(4):c173-80. PubMed ID: 16636585
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical presentation and outcome of autosomal dominant polycystic kidney disease in Pakistan: a single center experience.
    Rabbani MA; Ali SS; Murtaza G; Ahmad B; Maria Q; Siddiqui BK; Shah SM; Ahmad A
    J Pak Med Assoc; 2008 Jun; 58(6):305-9. PubMed ID: 18988388
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tissue Doppler imaging in the evaluation of left ventricular function in young adults with autosomal dominant polycystic kidney disease.
    Almeida EA; Oliveira EI; Lopes JA; Almeida AG; Prata MM
    Am J Kidney Dis; 2006 Apr; 47(4):587-92. PubMed ID: 16564936
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A link between the intrarenal renin angiotensin system and hypertension in autosomal dominant polycystic kidney disease.
    Kocyigit I; Yilmaz MI; Unal A; Ozturk F; Eroglu E; Yazici C; Orscelik O; Sipahioglu MH; Tokgoz B; Oymak O
    Am J Nephrol; 2013; 38(3):218-25. PubMed ID: 23988725
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Angiotensinogen and angiotensin II type 1 receptor gene polymorphism in patients with autosomal dominant polycystic kidney disease: effect on hypertension and ESRD.
    Lee KB; Kim UK
    Yonsei Med J; 2003 Aug; 44(4):641-7. PubMed ID: 12950120
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Renal and cardiac effects of antihypertensive treatment with ramipril vs metoprolol in autosomal dominant polycystic kidney disease.
    Zeltner R; Poliak R; Stiasny B; Schmieder RE; Schulze BD
    Nephrol Dial Transplant; 2008 Feb; 23(2):573-9. PubMed ID: 17984104
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Borderline hypertensive autosomal dominant polycystic kidney disease patients have enhanced production of renal dopamine. Normalization of renal haemodynamics by DOPA infusion.
    Barendregt JN; Florijn KW; Muizert Y; Chang PC
    Nephrol Dial Transplant; 1995; 10(8):1332-41. PubMed ID: 8538923
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Pathophysiology of Left Ventricular Hypertrophy, beyond Hypertension, in Autosomal Dominant Polycystic Kidney Disease.
    Oto OA; Edelstein CL
    Nephron; 2024; 148(4):215-223. PubMed ID: 35896062
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of VEGF polymorphism on progression of autosomal dominant polycystic kidney disease.
    Reiterová J; Obeidová H; Lenícek M; Stekrová J; Merta M; Maixnerová D; Vítek L; Viklický O; Tesar V
    Kidney Blood Press Res; 2008; 31(6):398-403. PubMed ID: 19060482
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Ambulatory 24-hour blood pressure monitoring of children and young adults with autosome dominant polycystic kidney degeneration].
    Geberth S; Zeier M; Schmidt KG; Mandelbaum A; Ritz E
    Z Kardiol; 1992; 81 Suppl 2():21-4. PubMed ID: 1514306
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interpretation of renal volume in autosomal dominant polycystic kidney disease and relevant clinical implications.
    Masoumi A; Elhassan E; Schrier RW
    Iran J Kidney Dis; 2011 Jan; 5(1):1-8. PubMed ID: 21189426
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparative study of three kidney biomarker tests in autosomal-dominant polycystic kidney disease.
    Casal JA; Hermida J; Lens XM; Tutor JC
    Kidney Int; 2005 Sep; 68(3):948-54. PubMed ID: 16105025
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exercise capacity in polycystic kidney disease.
    Reinecke NL; Cunha TM; Heilberg IP; Higa EM; Nishiura JL; Neder JA; Almeida WS; Schor N
    Am J Kidney Dis; 2014 Aug; 64(2):239-46. PubMed ID: 24787761
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.